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Understanding the structure, function, and evolution of genomes is a
central goal of genetics [1]. Oneway to pursue this goal is to unravel the
complex mechanism that controls the mRNA transcription rate of
multiple genes in a certain pathway. Recently, high-throughput
technologies, such as gene expression microarray and single nucleotide
polymorphism (SNP) chip, have made it possible to simultaneously
detect variations in gene expression level and DNA sequence in a large
number of genes. The gene expression data have been combined with
the genotype variation data to elucidate the genetics of gene expression
in experimental populations of model organisms such as yeast, mice,
and humans [2–6]. These studies are known as “expression quantitative
trait locus (eQTL) mapping” or “genetical genomics” [7] and have
revealed the global role of sequence variation in controlling gene
expression. Understanding the genetic mechanisms controlling gene
expression provides a way to discover complex networks of biological
processes, which underlie complex traits such as common human
multi-factorial diseases [8–10].Recent eQTL studies have treated gene expression levels as a
phenotype to identify polymorphic genetic variants that inﬂuence
differences in expression level by targeting individual genes. Accord-
ing to the locations of QTLs, an eQTL can be distinguished into 2 classes
of genetic variations: a cis-acting variation or a trans-acting variation.
A polymorphism in cis-regulatory regions (cis-acting variation) can
account for part of the genetic variation in expression by altering
functional motifs in the promoter region, or by the activity of the gene
product. In contrast, a polymorphism in one gene (trans-acting
variation) can affect the expression of other genes by triggering
feedback loops or by changing the coding sequence of a trans-acting
factor [11]. However, conducting a large number of tests to determine
associations between gene expression levels and genotype variations
leads to statistical issues, such as multiple testing and effective sample
size problems [12]. In particular, when subtle to modest alterations in
gene expression occur, depending on the genotype variation, these
statistical issues present obstacles to differentiating noise from actual
differences in the level of gene expression across genotypes. Although
gene expression levels can be measured on a genomic scale, eQTLs
have been detected for a single gene at a time, and thus, biological
interpretation based on this single-gene approach may have limita-
tions in explaining complex traits. Most complex traits, such as clinical
and physiological phenotypes, are multi-factorial, and hence, their
manifestation is usually regulated by multiple genes and/or environ-
mental factors. Phenotypic variation is unlikely to result from a simple
variation in DNA sequence and/or mRNA expression level of a single
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nisms, such as redundancy, feedback, and compensation [13].
Several approaches have been suggested to increase the statistical
power to detect differentially expressed genes [14,15]. One promising
approach was based on an idea that alterations in gene expression
mightmanifest at the level of biological pathways or co-regulated gene
sets, rather than individual genes. Subtle but coordinated changes in
expression might be detected more readily by combining measure-
ments across a set of multiple genes [14]. By employing the concept of
a “gene set” in genetical genomics research, one can identify genetic
modulators for mRNA transcription levels of multiple genes in a
biological pathway to characterize genetic variations that inﬂuence an
entire process. Such identiﬁed genetic modulators can indicate that a
perturbation in a particular gene induces a cascade of physiologic
events that affect all or many of the other genes in that particular
pathway.
In order to identify genetic modulators controlling functional
pathways in lymphoblast cells, Lee et al. [16] employed a peak
identiﬁcation algorithm (PIA) [17–19]. First, they examined the
association between the genetic variation at a genetic marker and
the transcriptional variation of every single gene. Then, a PIAwas used
to detect genetic markers (hereafter referred to as peaks) that have
signiﬁcant effects on the expression levels of each gene in a particular
gene set. The PIA is based on smoothing methods, which use the
moving average of “neighboring peaks” to enhance peaks and remove
spurious peaks. When constructing sliding windows for the moving
average and variance, they used the same ﬁxed numbers of adjacent
markers for every marker. Fisher's exact test [20] was then applied to
identify common peaks that affect the expression levels of multiple
genes in the gene set, under the assumption that the peaks observed
for a speciﬁc marker have the same distribution as those for all other
markers.
While this method provides a way to detect genetic regulators of a
whole pathway, it has 2 limitations. First, this PIA is based onwindows
containing the same ﬁxed numbers of adjacent markers for every
marker, and hence does not take into account the uneven marker
distribution that is common in whole genome research. Thus, direct
application of the PIA may not be appropriate for obtaining genotype
variation data measured at unevenly spaced markers across chromo-
somes or an entire genome. Since uneven marker distribution
represents unequal distance between markers, the windows for
different markers can have different sizes (i.e., widths) and can even
contain “neighboring” markers that are located far from the marker.
Although those distantly located markers may not play any biological
role as “neighbors,” they can have signiﬁcant effects on the calculation
of moving average and variance. In addition, PIA tends to be highly
dependent on tuning parameters such as the variance or the number
of neighboringmarkers for obtaining themoving average. Second, this
method cannot consider the possible linkage between a true common
regulatory locus of a gene set and its adjacent markers because the
single marker-based Fisher's exact test is used. Because of this linkage,
it is likely that false peaks for some individual genes in a gene set can
be detected in the neighborhood of the true common regulatory locus
at the ﬁrst step. Focusing only on individual markers rather than
marker regions, each of which contains adjacent multiple markers,
Lee et al. [16] used the single marker-based Fisher's exact test to
identify common peaks for a gene set, and hence failed to consider the
linkage between a real regulatory locus and adjacent markers.
In this study, we propose a new two-step method to overcome the
2 limitations of the previous approach suggested by Lee et al. [16]. The
genomic regions detected using our procedure can act as potential
genetic modulators whose sequence variation can inﬂuence the
transcriptional regulation of multiple genes involved in a biological
function. In the ﬁrst step, we developed aweighted peak identiﬁcation
algorithm (WPIA), which has 2 features that differentiate it from the
PIA. First, the moving average and variance for a speciﬁc marker arecomputed from its neighboring markers located within a ﬁxed width
of sliding windows. Because the WPIA takes into account distances
between markers by using the ﬁxed size of windows, it would be
appropriate for analysis of genotype variation data, particularly when
markers are not evenly distributed. Second, the use of the distance-
based weights reduces the effect of distant “neighboring” markers on
the calculation of moving average and variance, and thus, the WPIA
tends to select the most robust window size. In the second step, an
existing method based on a Poisson distribution [5] was employed to
detect common regulatory regions containing genetic modulators of
transcription processes for multiple genes in a gene set. The
simultaneous analysis of adjacent genetic markers allows us to
properly address the problem that peaks for individual genes can be
detected for differentmarkers because of their linkagewith a common
regulatory region.
In the following sections, we present the proposed two-step method
using WPIA and apply this method to an integrative dataset of gene
expression [4] and SNP genotypes [21]. Furthermore, biological inter-
pretation of the real data application demonstrates that the proposed
method successfully detects potential genetic modulators affecting
transcription processes of multiple genes in biological pathways.
2. Results and discussion
The proposed two-step procedure based on WPIA was applied to
CEPH gene expression [4] and SNP data [21] for identifying common
genetic modulators for expression rates of multiple genes in gene sets.
The expression data of 23,880 genes were measured from lympho-
blastoid cell lines of 167 individuals in 15 families from the CEPH/Utah
family collection. For each individual, genotyping was conducted at
2,756 autosomal SNP markers. Using external pathway information,
we previously searched for 454 gene sets that are related to biological
pathways. In order to apply the two-step procedure, the signiﬁcance
of the association between gene expression andmarker genotype was
calculated on the basis of a multipoint genome-wide linkage analysis
for each gene whose expression level is treated as a trait.
2.1. All 454 pathways
Using pathway information on Homo sapiens available from the
Kyoto Encyclopedia of Genes and Genomes (KEGG) [22], Gene Map
Annotator and Pathway Proﬁler (GenMAPP) [23], Pharmacogenetics
and Pharmacogenomics Knowledge Base (PharmGKB) [24], and
BioCarta (http://www.biocarta.com), we found 454 biological path-
ways, each of which contains 2–167 genes (14 genes on average)
proﬁled in the CEPH gene expression dataset. The proposed two-step
method was applied to each of these 454 pathways as a gene set to
identify common genetic modulators for multiple genes in the
pathway.
Using theWPIA, potential peaks were identiﬁed for individual genes
in eachof the454pathways. Inorder to identify regionswith evidenceof
clustering of genetic marker-expression associations for each pathway,
we grouped all SNPs into 1488 disjoint 2-Mbp-long intervals on the
whole genome according to their positions. The potential peaks were
then counted in each genomic interval across genes in a pathway, and
the statistical signiﬁcance of the genetic modulator was determined
using a Poisson distribution. Using a family-wise error rate (FWER) of
0.05 with Bonferroni correction [25] (p-value=7.40×10−8) and false
discovery rate (FDR) of 1.17×10−4 [26], we found 60 pathways, each of
which has 1–38 potential regulatory regions containing important
genetic modulators. For example, “chaperones modulate interferon
signaling pathway” appear to be regulated by a potential regulatory
region (20.7–22.7 Mbp) in chromosome 21 (Fig. 1A). Among the 16
proﬁled genes within this pathway, 8 genes were found to have a
potential genetic modulator (i.e., peak) at this regulatory region
Fig. 1. Genetic co-regulators of the “chaperones modulate interferon signaling pathway” identiﬁed using the proposed two-step method. (A) Potential regulatory region identiﬁed
for this pathway at chromosome 21. The negative logarithm of the p-value from step 2 was displayed at genomic positions in mega base pairs across the entire genome. Red
horizontal lines indicate the adjusted signiﬁcance level using Bonferroni correction. (B) Eight of the 16 expressed genes included in this pathway for which individual peaks were
identiﬁed on chromosome 21. Blue lines represent the smoothed association signiﬁcance; red circles represent the peaks detected; and black lines are the local smoothing variances.
The region in the red box represents a potential regulatory region that was identiﬁed for this pathway in (A).
388 E. Lee et al. / Genomics 97 (2011) 386–393(Fig. 1B). These potential regulatory regions were further investigated
for regulatory-region classiﬁcation, hotspots, and pathway complexity.
First, we classiﬁed the potential regulatory regions into those
acting “in cis” and those acting “in trans.” A “cis-acting” region is
deﬁned as a region that contains a genotypic polymorphism affecting
the expression level of a gene (say A), and lies within gene A itself orits regulatory region. A “trans-acting” region is deﬁned as a region that
contains a genotypic polymorphism affecting the expression level of
gene A, and is not usually located near gene A. For example, this region
could potentially lie in a different gene (say gene B) encoding a
transcription factor of gene A. For each pathway, we classiﬁed a
potential regulatory region as either a cis-acting region, if it lies within
389E. Lee et al. / Genomics 97 (2011) 386–39310 Mbp of any gene in the pathway, or as a trans-acting region, if it lies
outside these bounds. Of the 60 pathways surveyed, 16 were found to
have at least one potential cis-acting region. Results of the regulatory-
region classiﬁcation are presented for these 16 pathways in Table 1.
Because a cis-acting regulatory region of one gene can act as a trans-
acting regulator of other genes within a pathway through its own
transcriptional changes, the trans-acting regulatory genes, and not the
cis-acting regulatory gene, are likely to occur in the lower cascade of
the pathway. This ﬁnding was also obtained in our analysis of the 5
pathways, including the Chaperones modulate interferon signaling
pathway [27–33] in which 8 genes (IFNGR2, DNAJA3, IFNG, IFNGR1,
IKBKB, JAK2, RELA, and TP53) were investigated. On the basis of our
analysis, we identiﬁed a potential genetic modulator region for these
genes within 10 Mbp of IFNGR2. Thus, the transcriptional change of
IFNGR2 that is regulated by its own cis-acting regulatory region may
represent a candidate regulator of other genes in the pathway. This
ﬁnding suggests that IFNGR2 could be a potential master regulator of
the other 7 genes that lie at the lower cascade of the pathway.
Second, we identiﬁed 71 locus–pathway associations. All of the 71
potential regulatory regions were analyzed to detect “hotspots,” each
containing a genotypic polymorphism that affects the expression
levels of the genes in multiple pathways. For each potential regulatory
region, we counted the number of pathways for which a signiﬁcant
genetic modulator was identiﬁed at the region (Fig. 2). Out of 71
potential regulatory regions, 29 were related to more than one
pathway. We detected 9 candidate regions for hotspots, and these
regions were found to have more than 5 locus–pathway associations
(maximum, 13). Using the National Center for BiotechnologyTable 1
16 pathways having cis-acting regulatory regions.
Pathway Locationa Gene
AKT signaling pathway 17.7 (1) CASP9 (casp
ALK in cardiac myocytes 30.1 (14) BMP4b (bon
Antiarrhythmic drug pathways 108.5 (12) ATP2A2 (ATP
Cell Cycle 17.7 (1) E2F2 (E2F tr
Chaperones modulate interferon signaling pathway 20.7 (21) IFNGR2b (int
Cytokines and inﬂammatory response 193.7 (1) TGFB2 (tran
Electron transport chain 118.5 (12) COX6A1 (cyt
15.3 (17) SCO1 (SCO c
12.7 (21) ATP5J (ATP s
Erythrocyte differentiation pathway 193.7 (1) TGFB2 (tran
Glycogen metabolism 30.1 (14) PYGL (phosp
GPCRs class A Rhodopsin-like 17.7 (1) CNR2 (canna
HTR6 (5-hyd
33.7 (1) HCRTR1 (hy
6.3 (2) NTSR2 (neur
(opsin 1, me
12.3 (2) NTSR2 (neur
4.2 (4) ADRA2A (ad
88.0 (6) CNR1 (canna
(5-hydroxyt
91.0 (11) MTNR1B (m
10.5 (12) C3AR1 (com
GPR19 (G pr
108.5 (12) CMKLR1 (ch
30.1 (14) PTGDR (pros
74.9 (16) MC1R (mela
16.1 (20) SSTR4 (soma
46.1 (20) MC3R (mela
54.1 (20) HRH3 (hista
HIV-I Nef: negative effector of Fas and TNF 30.1 (14) MAP4K5b (m
PDGF signaling pathway 176.0 (3) PIK3CAb (ph
Peptide GPCRs 46.0 (20) MC3R (mela
Purine metabolism 20.7 (21) GARTb (phos
Pyrimidine metabolism 15.3 (17) NT5M (5',3'-
TGF beta signaling pathway 30.1 (14) BMP4b (bon
Each pathway contains at least one gene whose expression level is closely linked to a signi
a Starting location (Mbp) of 20 Mbp-long region on chromosome (chromosome).
b The genes which are placed in upper cascade and known to regulate activities of otherInformation Database (http://ncbi.nlm.nih.gov), we searched for
genes that are known to be located within these 9 regions to identify
potential trans-acting regulatory genes (marked in bold font in
Supplementary Table 1). We also found 5 genes located within each
regulatory region (marked in italic font in Supplementary Table 1);
however, because of the non-availability of expression levels in the
CEPH gene expression dataset, we could not ascertain whether these
regions were cis-acting regulatory regions. These 5 genes may
possibly regulate other genes through their transcriptional changes.
In fact, in chromosome 9, a group of 7 pathways appears to be
regulated by a potential regulatory region (126.5–128.5 Mbp). We
found that RPL35A, which lies within this regulatory region, belongs to
one of the 7 pathways, namely “ribosomal proteins.”
Using external sources, such as previous studies, and Gene
Ontology annotation (http://www.geneontology.org) (see genes
marked in a bold font in Supplementary Table 1), we identiﬁed
candidate trans-acting regulators among all of the investigated genes
in the 9 regions. While no candidate trans-acting regulator was found
in the region at 30.1–32.1 Mbp in chromosome 14, a total of 14
candidate trans-acting regulators were detected in the other regions.
One example, PAX7, is found in the potential regulatory region at
17.7–18.7 Mbp in chromosome 1 and appears to regulate 7 pathways.
Because PAX7, a member of a PAX family, is known to encode a
transcription factor [34], it would be a candidate trans-acting
regulator for those 7 pathways. Another example is TBP, located in
the potential regulatory region at 169.0–171.0 Mbp in chromosome 6;
TBP appears to be involved in the transcriptional regulation of 12
pathways. TBP is known to recognize the TATA box core promoterase 9, apoptosis-related cysteine peptidase)
e morphogenetic protein 4)
ase, Ca++ transporting, cardiac muscle, slow twitch 2)
anscription factor 2)
erferon gamma receptor 2)
sforming growth factor, beta 2)
ochrome c oxidase subunit VIa polypeptide 1)
ytochrome oxidase deﬁcient homolog 1)
ynthase, H+transporting, mitochondrial Fo complex, subunit F6)
sforming growth factor, beta 2)
horylase, glycogen, liver)
binoid receptor 2), HTR1D (5-hydroxytryptamine receptor 1D),
roxytryptamine receptor 6), HTR7 (5-hydroxytryptamine receptor 7)
pocretin receptor 1)
otensin receptor 2), OPN1LW (opsin 1 long-wave-sensitive), OPN1MW
dium-wave-sensitive), OPN1SW (opsin 1, short-wave-sensitive)
otensin receptor 2), OPN1lW (opsin 1, long-wave-sensitive)
renergic, alpha-2B-receptor), DRD5 (dopamine receptor D5)
binoid receptor 1), HTR1E (5-hydroxytryptamine receptor 1E), HTR1F
ryptamine receptor 1F)
elatonin receptor 1B)
plement component 3a receptor 1), C5AR1 (complement component 5a receptor 1),
otein-coupled receptor 19 ), LPAR5 (lysophosphatidic acid receptor 5)
emokine-like receptor 1)
taglandin D2 receptor ), PTGER2 (prostaglandin E receptor 2)
nocortin 1 receptor)
tostatin receptor 4)
nocortin 3 receptor)
mine receptor H3), MC3R (melanocortin 3 receptor)
itogen-activated protein kinase kinase kinase kinase 5)
osphoinositide-3-kinase, catalytic, alpha polypeptide)
nocortin 3 receptor)
phoribosylglycinamide formyltransferase), GDA (guanine deaminase)
nucleotidase, mitochondrial)
e morphogenetic protein 4)
ﬁcant regulatory region within 10 Mbp of its own location.
genes within the pathways.
Fig. 2. Hotspot search on 71 potential regulatory regions across the genome. The number of pathways for which a signiﬁcant genetic modulator was identiﬁed at each potential
regulatory region was displayed across the genome. The genome is divided into 1488 disjoint 2-Mbp-long intervals, shown in chromosomal order from the start of chromosome I to
the end of chromosome X. Of the 71 potential regulatory regions, 29 are related to more than one pathway, and 9 out of the 29 regions are good candidates for hotspots in that they
were found to have more than 5 locus–pathway associations.
390 E. Lee et al. / Genomics 97 (2011) 386–393element, and play a key role in the assembly of the preinitiation
complex during transcription [35,36].
Third, the complexity of a pathway was investigated by looking at
the number of potential regulatory regions that regulate the pathway
aswell as the number of genes contained in the pathway. Out of the 60
pathways, 35 had a single potential regulatory region, and 16 had
more than 2 regions. The most complex pathway was that of “GPCRs
class A rhodopsin-like,”which contains 167 genes and is regulated by
38 potential regulatory regions. “Antiarrhythmic drug,” “cell cycle,”
“electron transport chain,” and “ribosomal protein” pathways also
show high complexity in that at least 10 signiﬁcant regulatory regions
were identiﬁed for each pathway. These observations support the fact
that gene regulatory pathways are multi-factorial.2.2. Sixty pathways related to the immune system
The CEPH gene expression data were measured using mRNA
samples extracted from lymphoblastoid cells. Because lymphoblastoid
cells are components of the immune system, we further investigated
the results of the two-step analysis for each of the 60 pathways related
to the immune system. In 21 of these 60 pathways, we identiﬁed at
least 1 potential regulatory regionwith signiﬁcant genetic modulatorsFig. 3. Number of potential peaks identiﬁed via PIA and WPIA for the CHUK gene. (A) PIA wa
moving average and Nvar=the number of selected markers for obtaining the variance). Eac
various Nvar values. (B) WPIA was applied with various window sizes. The line represents(Supplementary Table 2), given an FWER of 0.05 with Bonferroni
correction (p-value=1.11×10−7, FDR=5.02×10−4). Among these
pathways, the “B cell survival pathway” seems to be regulated by a
potential regulatory region containing a T cell receptor beta locus
(TRB),which lies at 140.5–142.5 Mbp in chromosome 7. T cell receptor
beta loci are rearranged and expressed in response to several foreign
antigens. Furthermore, cytokines secreted by T cells help B cells
multiply and mature into antibody producers [37]. There are 13 other
pathways whose potential transcription factors are located within
their potential trans-acting regions.2.3. Discussion
By analyzing the CEPH gene expression and SNP data for randomly
selected genes, we compared the proposed WPIA with the PIA [16].
First, the PIA was applied with several different settings for 2
parameters (i.e., the numbers of adjacent markers used for obtaining
the moving average and the variance). For a particular gene, namely
CHUK, the number of potential peaks highly depends on both
parameters (Fig. 3A). Similar patterns have been observed in other
genes (not shown here). Since it is critical for the PIA to choose the
right parameters, a further investigation of the parameter choice iss applied with 2 parameters (Navg=the number of selected markers for obtaining the
h line represents the number of peaks computed with Navg as 3, 7, 11, 15, and 19 using
the number of peaks that were computed with various window sizes.
391E. Lee et al. / Genomics 97 (2011) 386–393needed. Second, we applied the window-based WPIA to the same
dataset. The number of potential peaks seemed unaffected by the
window width for most genes, including CHUK (Fig. 3B). Therefore,
the WPIA tends to be the robust parameter choice.
However, there are some limitations to the proposed method.
First, this method did not take into account the different number of
markers within the ﬁxed windows when detecting common peaks for
a gene set in the second step. Because the different number of markers
within the ﬁxed windows gives rise to different probabilities of
getting peaks in the ﬁrst step, further considerations should be taken
into account for the different number of markers within the ﬁxed
windows in the second step. Second, the proposedmethod is based on
the assumption that the number of peaks within a given marker
interval has a Poisson distribution. Although the Poisson assumption
is being commonly used in “hotspot” analyses, it still needs to be
veriﬁed. We plan to further investigate this problem in the future.
3. Conclusions
In this study, we have proposed a two-step method to identify
potential regulatory regions of a gene set that is deﬁned as a set of
genes included in a biological pathway. Because multiple genes in a
common pathway do not usually function in isolation, their
expression levels are likely to be correlated with each other. This
correlation among the expression levels of multiple genes in a
pathway could result from the fact that common genetic modulators
often exist and have an impact on the expression levels of multiple
genes in various ways. For example, a common modulator can be a
transcription factor (TF) that binds to TF-binding sites of multiple
genes, and thus it has a direct effect on regulating those genes.
Another example would be a genetic modulator of a gene whose
transcriptional change induces a cascade perturbation of other genes
in the same biological pathway. In other words, a genetic modulator
can regulate genes within a pathway in direct and/or indirect
manners. Thus, the impact of the genetic regulators would vary
across the genes, and it can be subtle on some genes that are indirectly
regulated or less variable. When a classical linkage analysis with a
strict threshold is conducted for determining the expression levels of
individual genes, it is difﬁcult to detect the subtle yet coordinated
perturbation in the expression level of multiple genes induced by
common genetic modulators [38]. In order to identify common
genetic regulators that inﬂuence a group of genes working in the same
pathway, we used a gene set approach in which we evaluated the
impact of sequence variations on the expression levels of multiple
genes.
For this purpose, we extended a peak identiﬁcation algorithm
(PIA), originally suggested by Lee et al. [16], for detecting pathway
regulators. Using the PIA, one can ﬁrst detect genetic markers with
relatively high and similar signiﬁcance patterns in a set. Common
peaks for a gene set are then identiﬁed via Fisher's exact test. While
Lee's method made it possible to detect markers that inﬂuence the
expression of the whole pathway, it has some limitations when
employed to genotype variation data. In order to overcome these
limitations, we developed a more appropriate PIA called the weighted
window-based PIA (WPIA) for genotype variation data; WPIA takes
into account distances for the moving average and variance using
windows of a pre-deﬁned size with distance-based weights. In the
second step, we proposed to detect regulatory regions using adjacent
genetic markers simultaneously on the basis of Poisson distribution,
rather than a speciﬁc marker using Fisher's exact test, so that we could
detect regulatory regions highly linked with the actual regulatory
region of the expression level of genes.
Unlike standard eQTL analyses, our method could identify the
regulatory regions that affect the expression level of multiple genes in
the same pathway, even though the effect is moderate for some genes
because of indirect regulation or less variable gene characteristics.Furthermore, our method is a knowledge-based approach in that gene
sets were identiﬁed using prior knowledge such as biological pathway
information in the literature and public databases. This approach
enabled us to obtain modulators of the whole pathway rather than
individual genes and to obtain a more functional inference. Such
identiﬁed genetic modulators can indicate that a perturbation in a
particular gene induces a cascade of physiologic events that affect all
or many of the other genes in that particular pathway. The expression
of a complex trait is usually multi-factorial and affected by multiple
genes, some of which may be regulated by a common modulator.
Therefore, our approach is more appropriate for explaining complex
traits.
Our analysis of real data demonstrates that this new two-step
method can successfully identify regulatory regions that control
multiple genes in pathways. By dissecting the identiﬁed regulatory
regions using gene information, we have identiﬁed transcription
factors that are adjacent to correlated SNPs and possibly linked to the
regulation of target pathway genes. Furthermore, our procedure
suggests the possible presence of additional cis-acting modulators
that may have an indirect inﬂuence on the expression of other genes
in the same pathway, even when expression data for some of those
other genes are unavailable.
4. Materials and methods
4.1. Two-step procedure to identify genetic modulators of multiple gene
expression
In order to identify genetic modulators controlling the expression
levels of multiple genes, we propose a stepwise procedure using
association signiﬁcance. In the ﬁrst step, we identiﬁed potential
genetic modulators whose genetic variations have a signiﬁcant
association with the expression levels of individual genes. Those
potential genetic modulators are identiﬁed as “peaks” via a new
weighted peak identiﬁcation algorithm (WPIA) based on a ﬁxed
window size. Because the association signiﬁcances at 2 close genetic
markers are likely to be dependent on one another, spurious peaks
can be falsely identiﬁed near a true genetic modulator. Smoothing
methods with sliding windows can be used to remove these spurious
peaks [17,18]. To determine the expression level of an individual gene,
we examined the existence of a peak at a marker by considering
association signiﬁcances at the marker and its neighboring markers
within the ﬁxed window size. The effects of distant neighboring
markers are penalized via distance-based weights. In the second step,
we identiﬁed genetic modulators of expression levels for multiple
genes. The number of peaks identiﬁed for multiple genes within a
speciﬁc marker interval is assumed to have a Poisson distribution [5].
We tested the signiﬁcance of sharing peaks within a speciﬁc marker
interval on the basis of the Poisson assumption.
Let G be a “gene set” of genes whose expression levels are assumed
to be regulated together in a particular pathway, and letM be a set of
genetic markers that have been genotyped using a SNP chip. We
denote S(g,m) as an association or linkage signiﬁcance between the
expression level of a gene g∈G and the genotype of a genetic marker
m∈M. For example, S(g,m) can be the negative logarithm of the p-value
at markerm∈M from a linkage analysis in which the gene expression
level of gene g∈G is treated as a trait. {S(g,m), ∀m∈M} are ordered
according to the marker position on the whole genome. Higher values
of S(g,m) indicate a stronger effect of the genotype variation of marker
m on the expression level of gene g.
4.1.1. STEP 1: identiﬁcation of genetic modulators for individual genes by
using the weighted peak identiﬁcation algorithm (WPIA)
In order to account for both measurement errors and dependency
among adjacent association signiﬁcances, we proposed a test statistic
based on weighted moving average of the signiﬁcances of a marker
392 E. Lee et al. / Genomics 97 (2011) 386–393and its adjacent genetic markers within a predetermined window
size. For a given g∈G and m∈M, the weighted moving average test
statistic is as follows:
T g;mð Þ =
S g;mð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Varˆ S g;mð Þ
 r ; ð1Þ
where the moving average and variance are calculated as
S g;mð Þ =
∑
i∈Im
wiS g;ið Þ
∑
i∈Im
wi
and V aˆr Sg;m
 
=
∑
i∈Im
w2i S g;ið Þ−S g;mð Þ
 2
∑
i∈Im
wi
 !2 ;
respectively.
Im is the index set of markers within a ﬁxed size of the sliding
window for marker m, and wi is the weight for marker i. Assuming
that the distance (di) between markers i and m has an exponential
distribution, we develop the weight proportional to the probability
density of the distance:
wi = λexp −λ × dið Þ; ð2Þ
where λ represents the mean number of markers within 1 Mbp.
On the basis of a certain threshold c, we assigned an initial peak at
marker m for a given gene g as below:
P g;mð Þ = 1 if T g;mð Þ N c and S g;mð Þ≥S g;m′  for all m′∈ Im
0 otherwise
(
ð3Þ
For example, a threshold could be determined via permutations
depending on the signiﬁcance level. The initial peaks are further
screened via Ripley's K function [39] to exclude falsely detected peaks
[40]. In other words, an initial peak at a speciﬁc marker is identiﬁed as
a potential peak if its association signiﬁcance is higher than the
“average” association signiﬁcance of its neighboring markers.
4.1.2. STEP 2: identiﬁcation of common genetic modulators for a gene set
For each gene set, we detected common peaks in a genomic region
containing multiple markers, on the basis of the potential peaks for
individual genes in the gene set. Genomic regions are then identiﬁed
using the evidence of genetic modulators affecting the transcription
processes of multiple genes in a pathway. We consider these
identiﬁed genomic regions as gene regulatory regions because their
sequence variation could possibly play a regulatory role in the
transcription process.
First, we divided the whole genome into genomic intervals of
equal length and computed the number of peaks identiﬁed at any
markers within each genomic interval (R) for any gene in the gene set
(G):
N R;Gð Þ = ∑
m∈R
∑
g∈G
P g;mð Þ ð4Þ
Second, we applied the approach suggested by Morley et al. [5] to
test the signiﬁcance of the sharing peaks within intervals for a gene
set G by assuming that N(R,G) is distributed as a Poisson distribution.
This procedure allows for simultaneous analysis of adjacent peaks that
are detected for individual genes in a gene set at STEP 1, and that may
be linked with a real regulatory locus. For multiplicity correction, we
employed false discovery rate (FDR) [26] along with Bonferroni's
correction [25] of family-wise error rate (FWER).4.2. Data and linkage analysis
4.2.1. CEPH gene expression and SNP data
The expression data were obtained from the study performed by
Monks et al. [4] and were assessed for 15 families from the CEPH/Utah
family collection (CEPH 1334, 1340, 1345, 1346, 1349, 1350, 1358,
1362, 1375, 1377, 1408, 1418, 1421, 1424, and 1477). The mRNA
expression levels of 23,880 genes were measured in lymphoblastoid
cell lines. While the 15 families contain 3 generations and 210
individuals, data for only 167 individuals were provided because of
the quantity and quality of RNA samples used for expression proﬁling.
For each of the individuals whose lymphoblastoid cells were
phenotyped, 2,756 autosomal SNP markers were genotyped [21],
and these SNP genotype data are available at the SNP Consortium
database of the SNP Consortium Linkage Map Project (http://snp.cshl.
org/downloads/index.html.en). Most SNPs in the SNP Consortium
database are clustered in very closely linked sets (2 or 3 SNPs within
100 kilo base pairs) with an average intercluster distance of
approximately 3 mega base pairs (Mbp).
4.2.2. Linkage analysis
In order to determine the association signiﬁcance between gene
expression and marker genotype, we used the negative logarithm of
the p-value at a marker position for each gene whose expression level
was treated as a trait in a multipoint genome-wide linkage analysis. In
particular, the analysis was performed using SIBPAL, a subroutine of
the software package SAGE [41], which is supported by a U.S. Public
Health Service Resource Grant (RR03655) from the National Center
for Research Resources. Pairwise phenotype differences between
siblings were weighted using the option (W4) of SIBPAL.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ygeno.2011.03.006.
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